Bistos Co., Ltd. Stock: price and insider trades · South Korea

Bistos Co., Ltd. is a Health Care company. Its directors and officers file their transactions with DART (FSS). 6 insiders have disclosed 17 filings since 2 November 2025.

Both sides are active: 7 purchases and 8 sales, from 3 insiders and 3 insiders respectively. The totals do not cover 15 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 major shareholder and 1 board member.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 17 filings, this issuer sits above that mark. Looking back to 2022, when coverage begins, insiders filed 7 purchases and 16 sales.

The most recent open-market purchase was published on 22 June 2026, 139 days ago. The median gap between a trade and its publication by DART (FSS) is 7 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.